We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CONMED
CNMD
$1.47B
| $6.94M | ﹤0.01% |
86,525
-79,971
| -48% | -$7.54M |
|
1677
Methode Electronics
MEI
$592M
| $6.94M | ﹤0.01% |
186,698
-4,164
| -2% | -$163K |
|
|
DQ
1678
Daqo New Energy
DQ
$996M
| $6.93M | ﹤0.01% |
130,500
+8,100
| +7% | +$517K |
|
1679
RPC Inc
RES
$1.3B
| $6.88M | ﹤0.01% |
992,807
+269,184
| +37% | +$1.95M |
|
1680
First Financial Corp
THFF
$969M
| $6.86M | ﹤0.01% |
151,857
-855
| -0.6% | -$39.5K |
|
1681
Remitly
RELY
$5.14B
| $6.85M | ﹤0.01% |
616,285
+17,952
| +3% | +$187K |
|
|
GAP
1682
The Gap Inc
GAP
$7.37B
| $6.85M | ﹤0.01% |
834,214
-27,690
| -3% | -$260K |
|
1683
TechTarget
TTGT
$278M
| $6.84M | ﹤0.01% |
115,511
-4,104
| -3% | -$264K |
|
1684
Herbalife
HLF
$1.29B
| $6.8M | ﹤0.01% |
341,884
+17,833
| +6% | +$442K |
|
1685
Grand Canyon Education
LOPE
$3.98B
| $6.8M | ﹤0.01% |
82,678
-9,157
| -10% | -$793K |
|
|
AZEK
1686
DELISTED
The AZEK Co
AZEK
| $6.8M | ﹤0.01% |
408,911
-200,312
| -33% | -$3.81M |
|
|
NAPA
1687
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $6.79M | ﹤0.01% |
470,513
+365,414
| +348% | +$6.54M |
|
1688
Nuveen ESG 1-5 Year US Aggregate Bond ETF
NUSA
$34.6M
| $6.78M | ﹤0.01% |
300,000
| – | – |
|
1689
Wayfair
W
$14.6B
| $6.77M | ﹤0.01% |
208,061
-9,278
| -4% | -$490K |
|
1690
AeroVironment
AVAV
$9.45B
| $6.75M | ﹤0.01% |
80,924
-25,014
| -24% | -$2.24M |
|
1691
Corcept Therapeutics
CORT
$12B
| $6.74M | ﹤0.01% |
263,044
-162,954
| -38% | -$4.36M |
|
1692
Gentherm
THRM
$1.27B
| $6.72M | ﹤0.01% |
135,104
-5,419
| -4% | -$328K |
|
1693
Benchmark Electronics
BHE
$2.96B
| $6.72M | ﹤0.01% |
271,112
+6,796
| +3% | +$174K |
|
1694
Clear Channel Outdoor Holdings
CCO
$1.23B
| $6.71M | ﹤0.01% |
4,897,930
-801,012
| -14% | -$1.21M |
|
|
CPE
1695
DELISTED
Callon Petroleum Company
CPE
| $6.7M | ﹤0.01% |
191,464
+44,204
| +30% | +$1.77M |
|
1696
Ameresco
AMRC
$1.36B
| $6.7M | ﹤0.01% |
100,778
+11,934
| +13% | +$733K |
|
1697
Alkami Technology
ALKT
$2.11B
| $6.66M | ﹤0.01% |
442,528
+98,595
| +29% | +$1.44M |
|
1698
Brown-Forman Class A
BF.A
$13.3B
| $6.65M | ﹤0.01% |
98,459
-4,842
| -5% | -$347K |
|
1699
ACV Auctions
ACVA
$1.3B
| $6.65M | ﹤0.01% |
924,759
-70,158
| -7% | -$557K |
|
1700
PVH
PVH
$4.04B
| $6.64M | ﹤0.01% |
148,243
-25,811
| -15% | -$1.53M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.